查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1983949

醫學影像市場：2026-2032年全球市場預測（依影像方式、組件、技術類型、最終用戶和應用分類）

Diagnostic Imaging Market by Modality, Component, Technology Type, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療影像市場價值將達到 296.5 億美元，到 2026 年將成長至 313.1 億美元，到 2032 年將達到 435.3 億美元，複合年成長率為 5.64%。

主要市場統計數據
基準年 2025 296.5億美元
預計年份：2026年 313.1億美元
預測年份：2032年 435.3億美元
複合年成長率 (%) 5.64%

針對不斷發展的診斷影像生態系統提供權威指導，重點在於臨床優先事項、技術整合和採購實際情況，以便做出明智的決策。

診斷影像領域正經歷一場變革，技術、​​監管和組織等多面向因素的整合加速了這項變革。醫療服務提供者和技術供應商都面臨著提升臨床處理能力、提高診斷準確性以及在整個診療過程中展現價值的壓力。同時，硬體小型化、高階軟體分析和雲端工作流程等方面的創新正在重塑診斷成像服務的交付和使用方式。

對人工智慧、模組化硬體、資料互通性和監管獎勵如何重塑診斷成像交付和供應商策略進行清晰分析。

在診斷影像領域，一場變革正在發生，它重新定義了資本密集型設備與軟體主導的臨床支援之間的平衡。先進的分析技術和人工智慧模型正從概念驗證（PoC）階段走向常規臨床支持，在許多醫療機構中得到應用，加速了工作流程自動化、影像重建、關鍵觀察的優先排序以及處方箋格式報告的生成。這些功能重新激發了人們對軟體優先策略和供應商夥伴關係的興趣，這些策略和合作將設備功能與雲端原生分析相結合。

2025 年的關稅環境將如何重塑整個診斷影像生態系統的採購趨勢、供應商策略和供應鏈韌性？

2025年關稅和貿易措施的實施給診斷影像設備及其組件的整個供應鏈和採購管道帶來了巨大壓力。關稅上漲及相關的合規要求延長了前置作業時間，尤其是那些從地理位置集中的供應商採購的關鍵組件和子系統。醫療服務提供者和供應商被迫調整價格、重新談判供應商合約並修改庫存策略，以維持服務的連續性並確保資金用於患者照護。

從詳細的觀點揭示了影響臨床採用和採購選擇的模式、組件、最終用戶、應用和技術類型的趨勢。

深入的市場細分揭示了臨床需求與技術能力相符的領域，以及投資能帶來最大營運效益的領域。檢驗不同影像方式的差異可知，電腦放射影像（CT）包括錐狀射束CT、常規CT和可攜式CT，每種CT在門診、急診和術中環境中都具有獨特的提案。磁振造影（MRI）涵蓋高場MRI、低場MRI和超高場MRI，在空間解析度、可及性和營運成本之間各有優劣。核子醫學分為專門的正子斷層掃描（PET）和單光子發射斷層掃描（SPECT），它們驅動腫瘤學和循環系統的通訊協定；而超音波技術（從2D到超音波、超音波和超音波）的應用範圍十分廣泛，從臨床分診到高級介入影像均有涉及。 X光透過不斷發展的電腦放射成像（CR）數位放射線（DR）繼續發揮基礎性作用，這兩種成像方式優先考慮劑量效率和快速的數位化工作流程。

美洲、歐洲、中東和非洲以及亞太地區的實施模式、監管複雜性和採購趨勢的區域策略分析

受報銷模式、管理體制和製造地等因素的影響，區域趨勢持續影響不同地區的普及程度，有的地區普及速度趨於平緩，有的地區則成長加速。在美洲，對企業影像、人工智慧整合和基於價值的醫療服務的投資，優先考慮臨床療效和效率，推動大規模醫療系統採用先進技術，同時也催生了區域醫院和門診中心對中端設備的需求。公共和私人支付方結構影響採購時機和資金分配，進一步凸顯了證明治療效果和處理能力提升的證據的重要性。

對現有硬體公司、軟體挑戰者和服務型供應商的競爭策略、夥伴關係和能力投資進行評估性概述，以區分它們。

診斷影像領域的競爭格局呈現出多元化的特點，既有成熟的硬體公司，也有快速發展的軟體專家，以及不斷壯大的服務供應商生態系統。成熟的設備製造商持續投資於平台現代化和現場服務改進，以保護其現有設備基礎並擴大服務主導收入。同時，軟體主導的新興參與企業和人工智慧專家正力圖在臨床決策支援、影像校正和工作流程自動化等領域主導地位，迫使現有供應商透過建立夥伴關係、進行收購或開發內部分析能力來規避競爭。

一項可行的分階段策略，旨在加強供應韌性，實現軟體和服務貨幣化，並使證據產生與支付方和監管機構的期望保持一致。

行業領導企業應採取一系列切實可行的分階段措施，以應對動盪的市場形勢，並從持續的技術變革中獲益。首先，應優先提升供應鏈韌性，具體措施包括供應商多元化、選擇替代零件來源以及引入能夠應對貿易政策波動的靈活合約條款。這將有助於降低交貨風險，確保臨床客戶的業務連續性。

透過嚴謹且多方面的研究途徑，結合與關鍵相關人員的訪談、技術檢驗和情境分析，得出與決策直接相關的見解。

本研究採用綜合分析調查方法，強調關鍵相關人員意見、技術文件和觀察分析的三角驗證，從而確保研究結果的穩健性和可操作性。主要研究包括對臨床負責人、採購負責人、現場工程師和技術主管進行結構化訪談，以收集關於特定設備性能、服務挑戰和部署障礙的第一手觀點。此外，還參考了技術白皮書、監管文件和產品文檔，以檢驗設備功能和合規性的演變。

為了確保診斷成像領域的長期價值，我們正在透過簡潔地整合關鍵優先事項，將技術創新、臨床結果和穩健的營運相結合。

診斷影像領域正處於一個轉折點，技術創新、服務模式和政策環境在此交匯，重新定義了臨床影像診斷的價值。如今，在供應鏈建構、軟體整合和服務能力方面的策略性選擇，將決定哪些機構能夠獲得臨床價值並保持競爭優勢。那些能夠從系統觀點出發，平衡硬體效能、軟體驅動的工作流程、人才儲備和資金籌措的相關人員，更有可能佔據優勢。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：診斷影像市場：依影像方式分類

  • 電腦放射成像
    • 錐狀射束CT
    • 常規電腦放射成像
    • 攜帶式電腦放射成像
  • 磁振造影
    • 高場磁振造影
    • 低場磁振造影
    • 超高場磁振造影
  • 核子醫學
    • 正子斷層掃描
    • 單光子發射斷層掃描
  • 超音波
    • 2D超音波
    • 3D超音波
    • 4D超音波
    • 多普勒超音波
  • X光
    • 電腦放射成像
    • 數位放射線攝影

第9章：診斷影像市場：按組件分類

  • 硬體
    • 線圈
    • 檢測器
    • 發電機
    • 感應器
  • 服務
    • 諮詢
    • 安裝
    • 維護
    • 訓練
  • 軟體
    • 人工智慧分析
    • PACS
    • 報告創建軟體
    • RIS

第10章：診斷影像市場：依技術類型分類

  • 2D影像診斷
  • 3D影像診斷
  • 4D影像診斷

第11章 醫療影像市場：依最終使用者分類

  • 診所
  • 診斷中心
  • 醫院
  • 研究機構

第12章：醫療影像市場：依應用領域分類

  • 循環系統
  • 牙科
  • 神經病學
  • 婦產科
  • 腫瘤學
  • 眼科
  • 整形外科

第13章：診斷影像市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：診斷影像市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：診斷影像市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫療影像市場

第17章：中國醫療影像市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • Allengers Medical Systems Ltd.
  • Analogic Corporation
  • Aurora Imaging Technologies, Inc.
  • BK Medical A/S
  • Bracco SpA
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • CurveBeam LLC
  • Esaote SpA
  • Fonar Corporation
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Mindray Medical International Limited
  • Neusoft Medical Systems Co., Ltd.
  • Planmed Oy
  • Quibim, SL
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
Product Code: MRR-CF6C60CF95AA

The Diagnostic Imaging Market was valued at USD 29.65 billion in 2025 and is projected to grow to USD 31.31 billion in 2026, with a CAGR of 5.64%, reaching USD 43.53 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 29.65 billion
Estimated Year [2026] USD 31.31 billion
Forecast Year [2032] USD 43.53 billion
CAGR (%) 5.64%

An authoritative orientation to the evolving diagnostic imaging ecosystem highlighting clinical priorities, technology convergence, and procurement realities for informed decision-making

The diagnostic imaging landscape is in a period of accelerated transformation driven by converging technological, regulatory, and organizational forces. Healthcare providers and technology vendors alike face mounting pressure to improve clinical throughput, enhance diagnostic accuracy, and demonstrate value across episodes of care. At the same time, innovation in hardware miniaturization, advanced software analytics, and cloud-enabled workflows is reshaping how imaging services are delivered and consumed.

This executive summary orients leaders to the structural changes affecting clinical imaging programs and supplier strategies. It synthesizes cross-cutting themes that matter most to decision-makers responsible for capital planning, clinical integration, and vendor selection. The intent is to provide a concise, evidence-based primer that highlights risks, strategic levers, and near-term operational priorities without presuming a single one-size-fits-all solution.

Readers will find a balanced discussion that connects modality-specific advances to broader trends in software, services, and regulatory pathways. The narrative emphasizes practical implications for procurement cycles, clinical adoption, and organizational readiness, and outlines recommended strategic responses that preserve clinical quality while enabling cost-effective modernization. By grounding strategic choices in operational realities, the introduction sets the stage for deeper examination of shifts, policy impacts, segmentation nuances, regional dynamics, and recommended actions.

A clear-eyed analysis of how AI, modular hardware, data interoperability, and regulatory incentives are reshaping diagnostic imaging delivery and vendor strategies

Diagnostic imaging is undergoing transformative shifts that are redefining the balance between capital-intensive equipment and software-driven clinical augmentation. Advanced analytics and AI models have moved beyond proof-of-concept to routine clinical augmentation in many centers, accelerating workflow automation, image reconstruction, prioritization of critical findings, and prescriptive reporting. These capabilities are driving renewed interest in software-first strategies and vendor partnerships that blend device performance with cloud-native analytics.

Simultaneously, hardware evolution is focusing on portability, lower-field magnetic resonance systems, modular computed tomography platforms, and point-of-care ultrasound arrays that enable decentralized diagnostics. These hardware trends are complemented by improvements in detector sensitivity and image processing that reduce radiation exposure and improve patient comfort, thereby influencing clinical protocols and utilization patterns. Convergence between imaging modalities and interventional procedures is intensifying as imaging platforms increasingly support therapeutics, image-guided interventions, and hybrid operating room workflows.

Operationally, interoperability and data governance have emerged as central imperatives; institutions demand systems that integrate with electronic health records and clinical decision support while maintaining cybersecurity and patient privacy. Suppliers are responding with federated learning approaches, encrypted data exchange, and tighter integration frameworks. Finally, regulatory pathways and value-based reimbursement models are incentivizing quantifiable improvements in patient outcomes and throughput, shifting procurement decisions toward demonstrable clinical and economic value rather than purely technical specifications.

How the 2025 tariff environment has reshaped procurement dynamics, supplier strategies, and supply chain resilience across diagnostic imaging ecosystems

The introduction of tariffs and trade measures in 2025 imposed material pressures across supply chains and procurement pathways for diagnostic imaging equipment and components. Increased duties and related compliance requirements have amplified lead times for critical assemblies and subsystems, particularly those sourced from geographically concentrated suppliers. Providers and vendors have had to navigate price adjustments, renegotiate supplier contracts, and reassess inventory strategies to maintain service continuity and preserve capital allocation toward patient care.

In practical terms, tariffs affected both end-equipment pricing and component-level economics, prompting manufacturers to evaluate alternate sourcing, regionalize production where feasible, and accelerate design changes that reduce reliance on tariff-affected parts. The cumulative effect tightened margins for some suppliers while catalyzing investment in supply chain resilience. For healthcare organizations, procurement cycles lengthened as contract teams incorporated tariff clauses and contingency planning into RFPs, and capital committees weighed the timing of purchases against potential cost volatility.

Beyond procurement, the tariff environment influenced strategic partner selection and innovation roadmaps. Vendors with diversified manufacturing footprints and robust services networks were better positioned to absorb incremental costs and maintain delivery commitments. Meanwhile, smaller suppliers faced intensified pressure to reprice or pivot toward service-oriented models. Overall, the 2025 tariff landscape reinforced the strategic importance of supply chain due diligence, flexible contracting, and collaborative vendor relationships that prioritize transparency and shared risk mitigation.

A granular segmentation-based perspective revealing modality, component, end-user, application, and technology type dynamics that drive clinical adoption and procurement choices

Insightful segmentation reveals where clinical demand aligns with technological capability and where investment will unlock the greatest operational leverage. When examining modality distinctions, computed tomography spans cone beam computed tomography, conventional computed tomography, and portable computed tomography each with distinct value propositions in ambulatory, emergency, and intraoperative settings. Magnetic resonance imaging encompasses high-field magnetic resonance imaging, low-field magnetic resonance imaging, and ultra-high-field magnetic resonance imaging, with trade-offs among spatial resolution, accessibility, and cost to operate. Nuclear medicine divides into positron emission tomography and single photon emission computed tomography specialties that drive oncology and cardiology protocols, while ultrasound technologies-from 2D ultrasound to 3D ultrasound, 4D ultrasound, and Doppler ultrasound-serve a broad continuum from point-of-care triage to sophisticated interventional imaging. X-ray remains foundational through computed radiography and digital radiography formats that continue to evolve toward dose efficiency and rapid digital workflows.

Component-level segmentation frames where margins, service intensity, and upgrade cycles concentrate. Hardware elements such as coils, detectors, generators, and transducers determine baseline image quality and TCO, while services including consulting, installation, maintenance, and training underpin uptime and clinician adoption. Software suites composed of AI analytics, PACS, reporting software, and RIS increasingly act as differentiators for longitudinal clinical value, enabling diagnostics to scale across distributed settings. End-user segmentation captures heterogeneity in purchasing behavior and utilization patterns: clinics prioritize throughput and affordability, diagnostic centers focus on throughput and niche services, hospitals balance breadth of modalities with integration into complex care pathways, and research institutes emphasize experimental capability and advanced modality support. Application-based segmentation highlights where modality and software investments yield clinical impact across cardiology, dental, neurology, obstetrics and gynecology, oncology, ophthalmology, and orthopedics, each with unique imaging protocols and regulatory considerations. Finally, technology-type segmentation spanning 2D imaging, 3D imaging, and 4D imaging frames the progression from planar diagnostics to volumetric and temporal analyses that support procedural planning and longitudinal monitoring.

Taken together, these segmentation layers illuminate strategic vectors for suppliers and providers: modular hardware investments should align with the dominant clinical use cases of each end-user type, software and services must be tailored to modality-specific workflows, and training and maintenance offerings must scale to the technical complexity of advanced imaging types. Integrating segmentation intelligence into procurement and product roadmaps enables targeted innovation that addresses differential clinical value across settings and specialties.

A regional strategic breakdown of adoption patterns, regulatory complexity, and procurement behavior across the Americas, Europe Middle East & Africa, and Asia-Pacific landscapes

Regional dynamics continue to shape where adoption plateaus and where growth accelerates, driven by reimbursement models, regulatory regimes, and manufacturing footprints. In the Americas, investment in enterprise imaging, AI integration, and value-based care initiatives emphasizes clinical outcomes and efficiency, supporting uptake of advanced modalities in large health systems while also creating demand for mid-tier devices in community hospitals and outpatient centers. Public and private payer structures influence procurement timing and capital allocation, reinforcing the importance of evidence demonstrating improvements in outcomes and throughput.

Across Europe, Middle East & Africa, regulatory harmonization and diverse reimbursement environments create a mosaic of adoption trajectories. Western European centers often lead in early clinical adoption and integration of software-enabled workflows, while many markets in the Middle East invest selectively in high-end modalities for tertiary care hubs. In parts of Africa, capacity constraints and workforce distribution underscore demand for portable and cost-efficient imaging solutions that maximize clinical reach. Vendors that adapt commercial models to local financing structures and prioritize service networks often gain traction in these varied contexts.

In Asia-Pacific, the interplay of domestic manufacturing capabilities, government-led healthcare expansion, and rapid urbanization drives a dual market: sophisticated tertiary centers in urban hubs adopt cutting-edge imaging and hybrid interventional suites, while extensive rural and peri-urban populations create demand for scalable, lower-cost modalities and tele-imaging services. Regional supply chains and local component manufacturing can mitigate tariff exposure and accelerate time-to-market for tailored solutions. Understanding these regional contours is essential to align product strategies, distribution partnerships, and clinical education programs with regional demand and operational realities.

An evaluative overview of competitive strategies, partnerships, and capability investments that differentiate hardware incumbents, software challengers, and service-focused providers

Competitive dynamics in diagnostic imaging are characterized by a blend of established hardware incumbents, fast-growing software specialists, and an expanding ecosystem of services providers. Established equipment manufacturers continue to invest in platform modernization and field service expansion to protect installed bases and extend service-driven revenue. At the same time, software-first entrants and AI specialists push the agenda on clinical decision support, image enhancement, and workflow automation, prompting legacy vendors to pursue partnerships, acquisitions, or in-house analytics development to remain competitive.

Strategic alliances between imaging manufacturers and cloud providers or analytics firms are becoming more common as vendors seek to offer integrated solutions rather than standalone devices. These collaborations prioritize joint go-to-market strategies that bundle hardware with subscription-based software and managed services, aligning incentives around uptime, outcomes, and continuous product improvement. Additionally, companies that build robust training and remote support capabilities differentiate through higher clinician adoption and lower total cost of ownership over the equipment lifecycle.

Mergers and targeted investments continue to reshape the vendor landscape, but differentiation increasingly rests on the ability to demonstrate clinical impact, regulatory compliance, and scalable deployment models. Organizations that excel in field service, data security, and interoperability are more successful at converting pilot projects into enterprise-wide deployments. New entrants that focus on modularity, affordability, and user-centered design find opportunities in outpatient centers and emerging markets, while premium offerings concentrate on high-acuity hospital systems and research facilities.

Actionable, phased strategies to strengthen supply resilience, monetize software and services, and align evidence generation with payer and regulatory expectations

Industry leaders should pursue a set of pragmatic, sequenced actions to navigate turbulence and capture upside from ongoing technological shifts. First, prioritize supply chain resilience by diversifying supplier bases, qualifying alternate component sources, and incorporating flexible contract terms that account for trade policy volatility. This will reduce delivery risk and protect operational continuity for clinical customers.

Second, accelerate software integration and modular design to enable incremental upgrades and subscription-based revenue streams. Organizations that separate hardware lifecycles from software innovation can offer continuous clinical improvements without forcing premature hardware replacement. Third, invest in services and workforce development: scaled installation, preventive maintenance, and clinician training programs increase adoption rates and protect brand reputation. These investments also create recurring revenue and strengthen customer relationships.

Fourth, align product development and evidence generation with payer and regulator expectations by supporting real-world evidence studies, health economic analyses, and interoperability standards. Demonstrating measurable improvements in diagnostic accuracy, time-to-treatment, or workflow efficiency will ease procurement and reimbursement hurdles. Fifth, pursue targeted regional strategies: localize pricing, financing, and service models to reflect regional payer structures and operational realities. Finally, embrace sustainability and lifecycle planning to reduce energy consumption, extend equipment longevity, and respond to institutional ESG commitments. Taken together, these actions create a resilient commercial model that balances innovation with operational reliability.

A rigorous, multi-method research approach combining primary stakeholder interviews, technical validation, and scenario analysis to generate decision-ready insights

This research synthesis relies on a blended methodology that emphasizes triangulation of primary stakeholder input, technical documentation, and observational analysis to ensure robustness and practical relevance. Primary research included structured interviews with clinical leaders, procurement officers, field engineers, and technology executives to capture firsthand perspectives on modality-specific performance, service challenges, and adoption barriers. These qualitative insights were supplemented with technical white papers, regulatory filings, and product literature to validate device capabilities and compliance trajectories.

Analytical approaches incorporated comparative feature mapping across modality types, component lifecycles, and software ecosystems, enabling consistent cross-sectional analysis. Scenario-based evaluation was applied to assess the operational implications of supply chain disruptions, policy shifts, and technology diffusion, while expert panels provided validation of synthesized findings to minimize interpretative bias. Throughout the process, data quality controls included source triangulation, version control for technical specifications, and sensitivity checks for qualitative assertions.

Limitations are acknowledged: proprietary sales data and institution-level procurement contracts were not accessible for confidentiality reasons, and regional heterogeneity means that some operational recommendations should be tailored locally. Nevertheless, the methodology emphasizes transparency, reproducibility, and practical applicability, providing decision-ready insight grounded in current clinical practice and vendor strategies.

A concise synthesis of pivotal priorities that unify technological innovation, clinical outcomes, and resilient operations to secure long-term value in diagnostic imaging

The diagnostic imaging sector stands at an inflection point where technological innovation, service delivery models, and policy environments converge to redefine what clinical imaging can deliver. Strategic choices made today around supply chain architecture, software integration, and service capabilities will determine which organizations capture clinical value and sustain competitive differentiation. Stakeholders that adopt a systems perspective-balancing hardware performance, software-enabled workflows, workforce readiness, and financing mechanisms-will be best positioned to translate innovation into routine clinical benefit.

The most successful pathways emphasize modularity, evidence-backed value propositions, and resilient operational models that can withstand policy and supply shocks. By focusing on interoperability, clinician adoption, and demonstrable improvements in diagnostic outcomes and throughput, providers and vendors can align incentives across the care continuum and enable more predictable procurement cycles. Ultimately, the sector's near-term priorities involve converting pilot-scale innovations into scalable, secure, and clinician-centric solutions that support patient access and institutional objectives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Diagnostic Imaging Market, by Modality

  • 8.1. Computed Tomography
    • 8.1.1. Cone Beam Computed Tomography
    • 8.1.2. Conventional Computed Tomography
    • 8.1.3. Portable Computed Tomography
  • 8.2. Magnetic Resonance Imaging
    • 8.2.1. High-Field Magnetic Resonance Imaging
    • 8.2.2. Low-Field Magnetic Resonance Imaging
    • 8.2.3. Ultra-High-Field Magnetic Resonance Imaging
  • 8.3. Nuclear Medicine
    • 8.3.1. Positron Emission Tomography
    • 8.3.2. Single Photon Emission Computed Tomography
  • 8.4. Ultrasound
    • 8.4.1. 2D Ultrasound
    • 8.4.2. 3D Ultrasound
    • 8.4.3. 4D Ultrasound
    • 8.4.4. Doppler Ultrasound
  • 8.5. X-Ray
    • 8.5.1. Computed Radiography
    • 8.5.2. Digital Radiography

9. Diagnostic Imaging Market, by Component

  • 9.1. Hardware
    • 9.1.1. Coils
    • 9.1.2. Detectors
    • 9.1.3. Generators
    • 9.1.4. Transducers
  • 9.2. Services
    • 9.2.1. Consulting
    • 9.2.2. Installation
    • 9.2.3. Maintenance
    • 9.2.4. Training
  • 9.3. Software
    • 9.3.1. AI Analytics
    • 9.3.2. PACS
    • 9.3.3. Reporting Software
    • 9.3.4. RIS

10. Diagnostic Imaging Market, by Technology Type

  • 10.1. 2D Imaging
  • 10.2. 3D Imaging
  • 10.3. 4D Imaging

11. Diagnostic Imaging Market, by End User

  • 11.1. Clinics
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals
  • 11.4. Research Institutes

12. Diagnostic Imaging Market, by Application

  • 12.1. Cardiology
  • 12.2. Dental
  • 12.3. Neurology
  • 12.4. Obstetrics/Gynecology
  • 12.5. Oncology
  • 12.6. Ophthalmology
  • 12.7. Orthopedics

13. Diagnostic Imaging Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Diagnostic Imaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Diagnostic Imaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Diagnostic Imaging Market

17. China Diagnostic Imaging Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies, Inc.
  • 18.6. Allengers Medical Systems Ltd.
  • 18.7. Analogic Corporation
  • 18.8. Aurora Imaging Technologies, Inc.
  • 18.9. BK Medical A/S
  • 18.10. Bracco S.p.A.
  • 18.11. Canon Medical Systems Corporation
  • 18.12. Carestream Health, Inc.
  • 18.13. CurveBeam LLC
  • 18.14. Esaote S.p.A.
  • 18.15. Fonar Corporation
  • 18.16. Fujifilm Holdings Corporation
  • 18.17. GE HealthCare Technologies, Inc.
  • 18.18. Hitachi, Ltd.
  • 18.19. Hologic, Inc.
  • 18.20. Hologic, Inc.
  • 18.21. Koninklijke Philips N.V.
  • 18.22. Mindray Medical International Limited
  • 18.23. Mindray Medical International Limited
  • 18.24. Neusoft Medical Systems Co., Ltd.
  • 18.25. Planmed Oy
  • 18.26. Quibim, S.L.
  • 18.27. Samsung Medison Co., Ltd.
  • 18.28. Samsung Medison Co., Ltd.
  • 18.29. Shimadzu Corporation
  • 18.30. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIAGNOSTIC IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DIAGNOSTIC IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONVENTIONAL COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONVENTIONAL COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONVENTIONAL COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABLE COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABLE COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABLE COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY LOW-FIELD MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY LOW-FIELD MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY LOW-FIELD MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA-HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA-HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA-HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GENERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GENERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GENERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRANSDUCERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRANSDUCERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRANSDUCERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY INSTALLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY INSTALLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY INSTALLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY AI ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY AI ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY AI ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PACS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PACS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PACS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REPORTING SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REPORTING SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REPORTING SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 288. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 289. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 290. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 291. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 292. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 293. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 294. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 295. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 296. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 297. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 298. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 306. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 308. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 315. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 316. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 317. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 318. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 319. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 320. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 321. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 322. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 323. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 324. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 325. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 326. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 329. G7 DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 330. G7 DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 331. G7 DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 332. G7 DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLIO